Kraig Biocraft Laboratories, Inc.Kraig Biocraft Laboratories, Inc.Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc.

No trades
See on Supercharts
Market capitalization
‪91.38 M‬USD
−0.0029USD
‪−3.03 M‬USD
‪775.38 M‬
Beta (1Y)
1.22

About Kraig Biocraft Laboratories, Inc.

Industry
CEO
Kim K. Thompson
Headquarters
Ann Arbor
Employees (FY)
7
Founded
2006
ISIN
US50075W1045
FIGI
BBG000V9T879
Kraig Biocraft Laboratories, Inc. operates as a biotechnology company, which focuses on the development and commercialization of spider silk. It specializes in the global textiles industry, genetic research and product development. The company was founded by Kim K. Thompson on April 25, 2006 and is headquartered in Ann Arbor, MI.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of KBLB is 0.0854 USD — it has decreased by 2.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Kraig Biocraft Laboratories, Inc. stocks are traded under the ticker KBLB.
KBLB stock is 8.43% volatile and has beta coefficient of 1.22. Check out the list of the most volatile stocks — is Kraig Biocraft Laboratories, Inc. there?
Yes, you can track Kraig Biocraft Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
KBLB stock has fallen by 1.95% compared to the previous week, the month change is a 4.04% fall, over the last year Kraig Biocraft Laboratories, Inc. has showed a 113.50% increase.
KBLB net income for the last quarter is ‪−1.32 M‬ USD, while the quarter before that showed ‪−549.27 K‬ USD of net income which accounts for −141.16% change. Track more Kraig Biocraft Laboratories, Inc. financial stats to get the full picture.
Today Kraig Biocraft Laboratories, Inc. has the market capitalization of ‪91.38 M‬, it has decreased by 15.54% over the last week.
No, KBLB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KBLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kraig Biocraft Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
KBLB reached its all-time high on May 13, 2019 with the price of 0.5070 USD, and its all-time low was 0.0020 USD and was reached on Mar 18, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 7.00 employees. See our rating of the largest employees — is Kraig Biocraft Laboratories, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kraig Biocraft Laboratories, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kraig Biocraft Laboratories, Inc. stock shows the buy signal. See more of Kraig Biocraft Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.